New 'Trojan Horse' Battle Strategy Against Ovarian Cancer

British scientists have successfully delivered a common chemotherapy drug to cancer cells inside tiny microparticles - a scientific breakthrough that offers hope to thousands of women battling ovarian cancer.

Researchers at Queen Mary, University of London, found that the drug reduced ovarian cancer tumours in an animal model by 65 times more than using the standard method.

Ovarian Cancer | Cancer in the Ovaries - Causes, Symptoms, Treatment & Prevention
Ovarian cancer affects both the ovaries and is referred to as the 'silent killer' as the symptoms go unnoticed until the disease advances.

"It's like we've made a re-enactment of the battle of Troy but on the tiniest scale. In Troy, the Greeks fooled the Trojans into accepting a hollow horse full of soldiers - we've managed to trick cancer cells into accepting drug-filled microparticles," said Dr Davidson Ateh.

Dr Ateh and his colleagues found that by coating tiny microparticles of around a hundredth the diameter of a human hair with a special protein called CD95, they could in fact trigger cancer cells into ingesting these particles.

The particles could also deliver a dose of a common chemotherapy drug called paclitaxel.

FDA Approves Biomarker Test for Ovarian Cancer
FDA approval last week facilitates nationwide use of tools that show the greatest specificity in estimating the risk of ovarian cancer in women with a pelvic mass.

The key to their success is that CD95 attaches to another protein called CD95L, which is found much more commonly on the surface of cancer cells than it is on normal healthy cells.

Once attached, the cancer cells ingest CD95 and the microparticle with it.

Scientists Discover Key Function of Mutation in Hereditary Breast and Ovarian Cancer Gene
Mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers

Inside the cell, the microparticle can unload its chemotherapy cargo, which kills the cell to reduce the size of the tumour.

"Other researchers had already noticed that cancer cells may use this CD95-CD95L arrangement to avoid being destroyed by the immune system, which is why they display more CD95L than normal cells. We've managed to turn this to our advantage and hijack the cancer cell's own trick-of-the-trade to get our 'Trojan Horse' through the gate," added Dr Ateh.

Tropical Plants to Cure Ovarian Cancer
Tropical plants could be used to fight ovarian cancer, suggest researchers at the Universities of Strathclyde and Portsmouth.

"This is an elegant method and if it works in a clinical setting as well as we hope it will patients could experience a better treatment with fewer side effects," said co-author Iain McNeish.

The study will be published next week in the journal Biomaterials.

Source-ANI